Brazilian study aims to unlock secrets of high potassium in heart and kidney patients

NCT ID NCT07370194

Recruiting now Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This study looks at data from over 6,000 Brazilian patients with heart failure, kidney disease, diabetes, or high blood pressure to understand how common high potassium levels (hyperkalemia) are and how doctors manage it. By analyzing medical records, researchers hope to identify risk factors and treatment patterns. The goal is to improve screening and care for this condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better identify and manage high potassium levels in patients with heart or kidney disease, leading to safer treatment approaches.
What could go wrong: This is an observational study that only looks at existing data, so it cannot prove cause and effect. Results may not apply to all patient groups or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease diabetes mellitus heart failure Hyperkalemia hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERKALEMIA

Contacts and locations

Locations

Research Site
RECRUITING

Curitiba, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.